Strategy for the consistent preparation of sufficient non-viral large chromosomal vectors for biopharmaceutical applications
Strategy for the consistent preparation of sufficient non-viral large chromosomal vectors for biopharmaceutical applications
批准号:
BB/E006019/1
负责人:
Eli Keshavarz -Moore
金额:
$48.16万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Modern medicines and therapies are becoming increasingly complex and specific for a particular disease or group of patients. One very specific type of therapy is Gene Therapy. Gene therapy is the use of genes as medicines. These genes can be delivered to patients either by the use of genetically modified viruses to carry the genes or by using non-viral methods which employ circular DNA molecules called plasmids isolated from bacteria. Both techniques are still in their infancy but are already promising huge medical advances in vaccination, cancer therapy and the correction of genetic disorders. However, viruses suffer from several drawbacks including safety considerations and limited to carry large genetic information. On the other hand large plasmid DNA molecules called BACs ( Bacterial Artificial Chromosomes) can be modified to incorporate a wide range of important control regions which allow expression of the gene in the correct tissue and at the correct time. This larger size poses a scientific and industrial challenge because the size limits the amount that can be made in a single bacterium, in addition, the size also calls for special processing considerations because BACs are fragile. The challenge is to be able to prepare the BAC molecules in the amounts needed to treat the numbers of people who could benefit from these medicines. We need to investigate then develop methods of making the DNA molecules at large scales in the biomanufacturing industry. The quality of the DNA molecules is also paramount. They need to be in the form that is most appropriate for delivering to humans (and animals) and free of contaminating material. The research we propose will enable industry to make DNA molecules that can be made at the large scales. The proposed research outcomes will allow others involved in gene therapy to prepare large DNA molecules for the treatment of cancers, for vaccines and to correct genetic disorders The science proposed will also allow other researchers in related disciplines to benefit from being able to make and manipulate large DNA constructs .We will also explore ways of making the DNA in the correct three dimensional form needed for efficient uptake into cells so that the DNA is an effective medicine.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Effect of the oxygen transfer rate on oxygen-limited production of plasmid DNA by Escherichia coli
氧转移速率对大肠杆菌限氧生产质粒 DNA 的影响
DOI:
10.1016/j.bej.2019.107303
发表时间:
2019
期刊:
Biochemical Engineering Journal
影响因子:
3.9
作者:
[Lara A]
通讯作者:
Lara A
DOI:
10.1002/bit.25971
发表时间:
2016-09
期刊:
Biotechnology and bioengineering
影响因子:
3.8
作者:
[Hassan S, Keshavarz-Moore E, Ward J]
通讯作者:
Ward J
Development of new-generation bacterial secretion process platforms
-
批准号:BB/K011243/1
-
项目类别:Research Grant
-
资助金额:$38.87万
-
财政年份:2013
-
负责人:Eli Keshavarz -Moore
-
依托单位:
BRIC DOCTORATE PROGRAMME-An upstream platform for the production of high grade heterologous proteins in Pichia pastoris
-
批准号:BB/J003867/1
-
项目类别:Training Grant
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Eli Keshavarz -Moore
-
依托单位:
Exploitation of Tat export machinery for protein production by bacteria
-
批准号:BB/G010501/1
-
项目类别:Research Grant
-
资助金额:$42.19万
-
财政年份:2009
-
负责人:Eli Keshavarz -Moore
-
依托单位:
海外基金